"Thromboembolism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
Descriptor ID |
D013923
|
MeSH Number(s) |
C14.907.355.590
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thromboembolism".
Below are MeSH descriptors whose meaning is more specific than "Thromboembolism".
This graph shows the total number of publications written about "Thromboembolism" by people in this website by year, and whether "Thromboembolism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 2 | 1 | 3 |
2006 | 2 | 0 | 2 |
2007 | 2 | 2 | 4 |
2009 | 1 | 1 | 2 |
2010 | 1 | 1 | 2 |
2011 | 1 | 0 | 1 |
2013 | 2 | 1 | 3 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 3 | 4 | 7 |
2017 | 41 | 15 | 56 |
2018 | 50 | 27 | 77 |
2019 | 18 | 9 | 27 |
2020 | 34 | 20 | 54 |
2021 | 30 | 11 | 41 |
To return to the timeline, click here.
Below are the most recent publications written about "Thromboembolism" by people in Profiles.
-
SARS-CoV-2 and splenic infarction: a rarely described thromboembolic presentation. Rev Esp Enferm Dig. 2022 01; 114(1):52-53.
-
Necessity of a Standardized Reporting System of Antiphospholipid Antibody Tests: Relevance for COVID-19. Ann Lab Med. 2021 11 01; 41(6):601-603.
-
Lipoprotein(a) and SARS-CoV-2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events. J Intern Med. 2022 01; 291(1):101-107.
-
Prophylactic anticoagulants for people hospitalized with COVID-19: systematic review. Br J Surg. 2021 Sep 27; 108(9):e299-e300.
-
Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment. Postgrad Med. 2021 Nov; 133(8):899-911.
-
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial. Am Heart J. 2021 12; 242:115-122.
-
Paraparesis due to aortic thromboembolism as a rare complication of COVID-19 infection. J Vasc Surg. 2021 09; 74(3):1047.
-
COVID-19 thromboembolic complications: Deepening immunoinflammatory features. J Vasc Surg. 2021 09; 74(3):1048-1049.
-
COVID-19 and coagulopathy. Clin Respir J. 2021 Dec; 15(12):1259-1274.
-
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021 08 26; 374:n1931.